Centre Antoine Lacassagne

This study is testing a combination of three drugs—gemtuzumab ozogamicin, cytarabine, and gilteritinib—for adults with a specific type of acute myeloid leukemia (AML) that has a FLT3 mutation and has come back or not responded to prior treatment. The main goals are to see if the …

This study is testing whether a specific type of internal radiation boost (called CXB) given after standard chemo-radiation is better than an external radiation boost at helping patients with early rectal cancer avoid major surgery that removes the rectum or requires a permanent …